ArticleScientific reports2025
Improving lung cancer pathological hyperspectral diagnosis through cell-level annotation refinement.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Segmentation Methodologies for the Construction of Hyperspectral Cell Nuclei Databases in Histopathology.Bioengineering (Basel, Switzerland) · 2026Article
- HMI-LUSC: A Histological Hyperspectral Imaging Dataset for Lung Squamous Cell Carcinoma.Scientific data · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Lung cancer remains a major global health challenge, and accurate pathological examination is crucial for early detection. This study aims to enhance hyperspectral pathological image analysis by refining annotations at the cell level and creating a high-quality hyperspectral dataset of lung tumors. We address the challenge of coarse manual annotations in hyperspectral lung cancer datasets, which limit the effectiveness of deep learning models requiring precise labels for training. We propose a semi-automated annotation refinement method that leverages hyperspectral data to enhance pathological diagnosis. Specifically, we employ K-means unsupervised clustering combined with human-guided selection to refine coarse annotations into cell-level masks based on spectral features. Our method is validated using a hyperspectral lung squamous cell carcinoma dataset containing 65 image samples. Experimental results demonstrate that our approach improves pixel-level segmentation accuracy from 77.33% to 92.52% with a lower level of prediction noise. The time required to accurately label each pathological slide is significantly reduced. While pixel-level labeling methods for an entire slide can take over 30 mins, our semi-automated method requires only about 5 mins. To enhance visualization for pathologists, we apply a conservative post-processing strategy for instance segmentation. These results highlight the effectiveness of our method in addressing annotation challenges and improving the accuracy of hyperspectral pathological analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.